vestarВестник аритмологииJournal of Arrhythmology1561-86412658-7327НАО «Инкарт»10.35336/VA-2020-2-40-44vestar-251Research ArticleОБЗОРREVIEWПерспективы неинвазивной аблации желудочковых тахикардий у больных со структурной патологией сердцаProspects for noninvasive ablation of ventricular tachycardia in patients with structural heart diseaseКоролевС. В.KorolevS. V.

Королев Сергей Владимирович

Sergey Korolev

sergejkorolev@ya.ruТроицкийА. В.TroitskiyA. V.ХабазовР. И.KhabazovR. I.ВосканянС. Э.VoskanyanS. E.ЗотовА. С.ZotovA. S.ВачевС. А.VachevS. A.ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий» ФМБА РоссииРоссияFSBI “Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies” FMBA of RussiaRussian FederationФГБУ «Государственный научный центр Российской Федерации - Федеральный медицинский биофизический центр имени А.И.Бурназяна» ФМБА РоссииРоссияFSBI “State Scientific Center of the Russian Federation - Federal Medical Biophysical Center named after A.I.Burnazyan” FMBA of RussiaRussian Federation2020240720202724044Copyright © Королев С.В., Троицкий А.В., Хабазов Р.И., Восканян С.Э., Зотов А.С., Вачев С.А., 20202020Королев С.В., Троицкий А.В., Хабазов Р.И., Восканян С.Э., Зотов А.С., Вачев С.А.Korolev S.V., Troitskiy A.V., Khabazov R.I., Voskanyan S.E., Zotov A.S., Vachev S.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://vestar.elpub.ru/jour/article/view/251

Описываются методы неинвазивной протонно-лучевой аблации аритмогенного субстрата желудочковых тахикардий у больных со структурной патологией сердца направленные на устранение триггеров и/или разрушение re-entry механизмов при помощи пучка протонов.

The method of non-invasive proton-beam ablation of an arrhythmogenic substrate of ventricular tachycardia in patients with structural heart disease is aimed at eliminating triggers and/or destroying re-entry mechanisms using a proton beam described.

желудочковая тахикардияпротонная терапиянеинвазивная аблацияventricular tachycardiaproton therapynon-invasive ablationReferencesMcNally B, Robb R, Mehta M, et al. Out-of-hospital cardiac arrest surveillance Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005 -December 31, 2010. CDC [Internet]. 2011 Jul. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/ss6008a1.htm.McNally B, Robb R, Mehta M, et al. Out-of-hospital cardiac arrest surveillance Cardiac Arrest Registry to Enhance Survival (CARES), United States, October 1, 2005 -December 31, 2010. CDC [Internet]. 2011 Jul. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/ss6008a1.htm.Tang P, Shenasa M, Boyle N. Ventricular arrhythmias and sudden cardiac death. Card Electrophysiol Clin. 2017;9(4):693-708. DOI: m.1016/j.ccep.2017.08.004.Tang P, Shenasa M, Boyle N. Ventricular arrhythmias and sudden cardiac death. Card Electrophysiol Clin. 2017;9(4):693-708. DOI: m.1016/j.ccep.2017.08.004.Moss AJ, Zareba W, Hall WJ, et al. Multicenter automatic defibrillator implantation trial II investigators prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl JMed. 2004; 346:877-883. DOI: 10.1056/NEJMoa013474Moss AJ, Zareba W, Hall WJ, et al. Multicenter automatic defibrillator implantation trial II investigators prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl JMed. 2004; 346:877-883. DOI: 10.1056/NEJMoa013474Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2009; 6:886-933. DOI: 10.1016/j.hrthm.2009.04.030.Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2009; 6:886-933. DOI: 10.1016/j.hrthm.2009.04.030.Mallidi J, Nadkarni G, Berger R, et al. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm. 2011; 8(4):503-10. DOI: 10.1016/j.hrthm.2010.12.015.Mallidi J, Nadkarni G, Berger R, et al. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm. 2011; 8(4):503-10. DOI: 10.1016/j.hrthm.2010.12.015.Cuculich PS, Schill MR, Kashani R, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017; 377:2325-2336/ DOI: 10.1056/NEJ-Moa1613773.Cuculich PS, Schill MR, Kashani R, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017; 377:2325-2336/ DOI: 10.1056/NEJ-Moa1613773.Robinson C, Samson P, Moore K, et al. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 2019; 139(3):313-321. DOI: 10.1161/CIRCULATIONA-HA.118.038261.Robinson C, Samson P, Moore K, et al. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 2019; 139(3):313-321. DOI: 10.1161/CIRCULATIONA-HA.118.038261.Silberbauer J. Future now: new technologies for treatment of ventricular tachycardia. Conference report. The Moscow international VT summit. October 2019. Available from: https://fnkc-fmba.ru/sobytiya/the-moscow-in-ternational-ventricular-tachycardia-summit.Silberbauer J. Future now: new technologies for treatment of ventricular tachycardia. Conference report. The Moscow international VT summit. October 2019. Available from: https://fnkc-fmba.ru/sobytiya/the-moscow-in-ternational-ventricular-tachycardia-summit.Knutson NC, Samson PP, Hugo GD, et al. Radiation therapy workflow and dosimetric analysis from a phase 1/2 trial of noninvasive cardiac radioablation for ventricular tachycardia. JRadiat Oncol Biol Phys. 2019; 104(5):1114-1123. DOI: 10.1016/j.ijrobp.2019.04.005.Knutson NC, Samson PP, Hugo GD, et al. Radiation therapy workflow and dosimetric analysis from a phase 1/2 trial of noninvasive cardiac radioablation for ventricular tachycardia. JRadiat Oncol Biol Phys. 2019; 104(5):1114-1123. DOI: 10.1016/j.ijrobp.2019.04.005.Graeff C, Bert C. Noninvasive cardiac arrhythmia ablation with particle beams. Med Phys. 2018; 45(11):1024-1035. DOI:10.1002/mp.12595.Graeff C, Bert C. Noninvasive cardiac arrhythmia ablation with particle beams. Med Phys. 2018; 45(11):1024-1035. DOI:10.1002/mp.12595.Mondlane G, Gubanski M, Lind PA, et al. Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases. Phys Med. 2017; 42:263-270. DOI: 10.1016/j.ejmp.2017.03.019.Mondlane G, Gubanski M, Lind PA, et al. Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases. Phys Med. 2017; 42:263-270. DOI: 10.1016/j.ejmp.2017.03.019.Wilson RR, Radiological use of fast protons. Radiology. 1946; 47:487-491; DOI: 10.1148/47.5.487.Wilson RR, Radiological use of fast protons. Radiology. 1946; 47:487-491; DOI: 10.1148/47.5.487.Goddu SM, Hilliard J, Knutson N, et al. Feasibility of noninvasive cardiac ablation utilizing intensity modulated proton therapy to treat ventricular tachycardia. International Journal of Radiation Oncology Biology Physics. 2018; 102(3):58. DOI:10.1016/j.ijrobp.2018.06.166.Goddu SM, Hilliard J, Knutson N, et al. Feasibility of noninvasive cardiac ablation utilizing intensity modulated proton therapy to treat ventricular tachycardia. International Journal of Radiation Oncology Biology Physics. 2018; 102(3):58. DOI:10.1016/j.ijrobp.2018.06.166.Hohmann S, Deisher AJ, Suzuki A, et al. Left ventricular function after noninvasive cardiac ablation using proton beam therapy in a porcine model. Heart Rhythm, 2019; 16(11):1710-1719. DOI: 10.1016/j.hrthm.2019.04.030.Hohmann S, Deisher AJ, Suzuki A, et al. Left ventricular function after noninvasive cardiac ablation using proton beam therapy in a porcine model. Heart Rhythm, 2019; 16(11):1710-1719. DOI: 10.1016/j.hrthm.2019.04.030.Lehmann HI, Deisher AJ, Takami M, et al. External arrhythmia ablation using photon beams: ablation of the atrioventricular junction in an intact animal model. Circ Arrhythm Electrophysiol. 2017;10(4). DOI:10.1161/CIR-CEP.116.004304.Lehmann HI, Deisher AJ, Takami M, et al. External arrhythmia ablation using photon beams: ablation of the atrioventricular junction in an intact animal model. Circ Arrhythm Electrophysiol. 2017;10(4). DOI:10.1161/CIR-CEP.116.004304.Suit H, DeLaney T, Goldberg S, et al. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol. 2010; 95(1):3-22. DOI: 10.1016/j.radonc.2010.01.015.Suit H, DeLaney T, Goldberg S, et al. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol. 2010; 95(1):3-22. DOI: 10.1016/j.radonc.2010.01.015.Bao C, Sun Y, Dong Y. et al. The relative biological effectiveness of proton and carbon ion beams in photon-sensitive and resistant nasopharyngeal cancer cells. Translational Cancer Research, 2018; 7(1):170-179. DOI: 10.21037/tcr.2018.01.25.Bao C, Sun Y, Dong Y. et al. The relative biological effectiveness of proton and carbon ion beams in photon-sensitive and resistant nasopharyngeal cancer cells. Translational Cancer Research, 2018; 7(1):170-179. DOI: 10.21037/tcr.2018.01.25.Lehmann HI, Graeff C, Simoniello P, et al. Feasibility study on cardiac arrhythmia ablation using high-energy heavy ion beams. Scientific Reports, 2016; 6: Article number: 38895. DOI: 10.1038/srep3889515.Lehmann HI, Graeff C, Simoniello P, et al. Feasibility study on cardiac arrhythmia ablation using high-energy heavy ion beams. Scientific Reports, 2016; 6: Article number: 38895. DOI: 10.1038/srep3889515.Dixon-Altaber H. CERN congratulates CNAO on a world’s first proton treatment of a cardiac pathology [Internet]. Available from: https://home.cern/news/news/knowledge-sharing/cern-congratulates-cn-ao-worlds-first-proton-treatment-cardiac-pathology?f-bclid=IwAR0SuY5ybzTuHdjdIS0EPLhjVgjnw1k_in-adHz9EnY8EzzRZ0U5sApwc5vM.Dixon-Altaber H. CERN congratulates CNAO on a world’s first proton treatment of a cardiac pathology [Internet]. Available from: https://home.cern/news/news/knowledge-sharing/cern-congratulates-cn-ao-worlds-first-proton-treatment-cardiac-pathology?f-bclid=IwAR0SuY5ybzTuHdjdIS0EPLhjVgjnw1k_in-adHz9EnY8EzzRZ0U5sApwc5vM.Sharma A, Wong D, Weidlich G, et al. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm, 2010; 7(6):802-10. DOI: 10.1016/j.hrthm.2010.02.010.Sharma A, Wong D, Weidlich G, et al. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm, 2010; 7(6):802-10. DOI: 10.1016/j.hrthm.2010.02.010.Blanck O, Bode F, Gebhard M, et al. Dose-escalation study for cardiac radiosurgery in a porcine model. Int J Radiat Oncol Biol Phys, 2014; 89(3):590-8. DOI: 10.1016/j.ijrobp.2014.02.036.Blanck O, Bode F, Gebhard M, et al. Dose-escalation study for cardiac radiosurgery in a porcine model. Int J Radiat Oncol Biol Phys, 2014; 89(3):590-8. DOI: 10.1016/j.ijrobp.2014.02.036.Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med, 2013; 368:987-998. DOI: 10.1056/NEJMoa1209825.Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med, 2013; 368:987-998. DOI: 10.1056/NEJMoa1209825.

The authors declare that there are no conflicts of interest present.